FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Reckitt Benckiser Mucinex DM Recall

Mucinex DM (guaifenesin 600mg and dextromethorphan HBr 30mg), extended-release bi-layer…

Reckitt Benckiser LLC · Parsippany, NJ

Risk level
Class III
Reported by FDA
Apr 29, 2015
Recall ID
D-0964-2015
Check your lot numberHow we source this data

Summary

Reckitt Benckiser recalled Mucinex DM starting Nov 10, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0964-2015 on Apr 29, 2015. Reason: Defective container: A customer complaint revealed the presence of a defective seal on the top of a Mucinex pouch. Status: Terminated.

Why it was recalled

Defective container: A customer complaint revealed the presence of a defective seal on the top of a Mucinex pouch

Product description

Mucinex DM (guaifenesin 600mg and dextromethorphan HBr 30mg), extended-release bi-layer tablets, 2 tablets per pouch (NDC 63824-056-72), OTC, Distributed by Reckitt Benckiser, Parsippany, NJ 07054-0224 Made in England

Lot numbers, UPCs & expiration codes

Lot BD375 exp 06/2016; BD566, BD661 exp. 08/2016

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0964-2015
Classification
Class III
Status
Terminated
Recall initiated
Nov 10, 2014
FDA report date
Apr 29, 2015
Quantity
155 cases (2000 pouches of 2 tablets per case)
Recall type
Voluntary: Firm initiated
Recalling firm
Reckitt Benckiser LLC

Original FDA data

Every field from FDA enforcement report D-0964-2015, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
70840
Address
399 Interpace Pkwy
Code information
Lot BD375 exp 06/2016; BD566, BD661 exp. 08/2016
Postal code
07054-1133
Report date
Apr 29, 2015
Product type
Drugs
Recall number
D-0964-2015
Classification
Class III
Recalling firm
Reckitt Benckiser LLC
Product quantity
155 cases (2000 pouches of 2 tablets per case)
Termination date
Mar 30, 2018
Reason for recall
Defective container: A customer complaint revealed the presence of a defective seal on the top of a Mucinex pouch
Voluntary / mandated
Voluntary: Firm initiated
Product description
Mucinex DM (guaifenesin 600mg and dextromethorphan HBr 30mg), extended-release bi-layer tablets, 2 tablets per pouch (NDC 63824-056-72), OTC, Distributed by Reckitt Benckiser, Parsippany, NJ 07054-0224 Made in England
Distribution pattern
Nationwide
Recall initiation date
Nov 10, 2014
Initial firm notification
Letter
Center classification date
Apr 21, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0964-2015, published Apr 29, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls